Posterior Intercostal Lymph Nodes Double Recurrence and Death Risk in Malignant Pleural Mesothelioma.

[1]  Hadley Wickham,et al.  ggplot2 - Elegant Graphics for Data Analysis (2nd Edition) , 2017 .

[2]  S. Hahn,et al.  Extended Pleurectomy-Decortication-Based Treatment for Advanced Stage Epithelial Mesothelioma Yielding a Median Survival of Nearly Three Years. , 2017, The Annals of thoracic surgery.

[3]  V. Rusch,et al.  The IASLC Mesothelioma Staging Project: Proposals for Revisions of the N Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Pleural Mesothelioma , 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[4]  B. Milleron,et al.  Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial , 2016, The Lancet.

[5]  J. V. van Meerbeeck,et al.  Treatment patterns and survival analysis in 9014 patients with malignant pleural mesothelioma from Belgium, the Netherlands and England. , 2015, Lung cancer.

[6]  J. Friedberg.  The state of the art in the technical performance of lung-sparing operations for malignant pleural mesothelioma. , 2013, Seminars in thoracic and cardiovascular surgery.

[7]  L. Simione,et al.  Number of mediastinal lymph nodes as a prognostic factor in PN2 non small cell lung cancer: a single centre experience and review of the literature. , 2014, Asian Pacific journal of cancer prevention : APJCP.

[8]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .